Urologic Health

About Urologic Health

Urologic Health Inc. is a medical device company developing non-invasive diagnostic technology for assessing bladder function. The firm addresses a significant gap in urological care, where traditional diagnostic methods are often invasive, painful, and uncomfortable, causing many patients to avoid necessary assessments for conditions like overactive bladder, urinary retention, and incontinence. The company was co-founded by CEO Adam Yaacov and Dr. Noam Omer, who have combined expertise in developing medical technologies that leverage AI-driven insights. Urologic Health was established and incubated at the MEDX Xelerator venture studio (now EdgeLabs) and is part of the Edge Medical Ventures portfolio, with operations in both Israel and the United States. In May 2026, the company announced it had secured $11 million in a seed financing round led by an undisclosed strategic investor, with participation from Edge Medical Ventures, SHD Partners, and Longevity Venture Partners. This capital is intended to fund clinical validation, support the FDA 510(k) regulatory pathway, and facilitate initial commercialization in the U.S. Urologic Health's core product is the niu™ System, a platform designed to provide catheter-free urodynamic testing. This system utilizes external sensors to convert bladder activity into clinically meaningful diagnostic data, eliminating the need for catheterization. Early feasibility studies have shown the system can capture significant bladder activity non-invasively. The technology is designed to make bladder function assessment easier for clinicians, painless for patients, and allows for routine, repeatable monitoring over time, in contrast to the one-time snapshots provided by invasive procedures. The niu™ System is currently for investigational use and has not yet been approved for sale in the United States. Keywords: bladder function monitoring, non-invasive urodynamics, medical device, catheter-free testing, urology diagnostics, Adam Yaacov, Noam Omer, niu System, Edge Medical Ventures, bladder dysfunction, overactive bladder, urinary retention, incontinence, MedTech, FDA 510(k)